Company news

MediWound Ltd. news in 2025

MediWound Ltd.'s news releases, calls and decks from 2025, newest first.

View company

MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

December 10, 2025

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 20, 2025

MediWound to Report Third Quarter 2025 Financial Results

November 5, 2025

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

November 3, 2025

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

September 29, 2025

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

September 25, 2025

MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

September 2, 2025

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

August 20, 2025

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 14, 2025

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

August 13, 2025

MediWound to Report Second Quarter 2025 Financial Results

August 4, 2025

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 21, 2025

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 13, 2025

MediWound to Report First Quarter 2025 Financial Results

May 5, 2025

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

April 28, 2025

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

March 19, 2025

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

March 3, 2025

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

February 25, 2025

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

February 24, 2025

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

February 11, 2025

MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

February 3, 2025

Calls in 2025

Decks in 2025